Drug Safety User Fees Explored By Sen. Grassley In Questions For Crawford
Executive Summary
Senate Finance Committee Chairman Charles Grassley is interested in the idea of funding FDA's drug safety activities with user fees
You may also be interested in...
PDUFA IV Is “Golden Opportunity” To Improve Drug Safety Funding And Staff
The current round of reauthorization of the Prescription Drug User Fee Act presents a "golden opportunity" to improve FDA's regulation of drug safety, according to the Institute of Medicine's Assessment of the U.S. Drug Safety System Committee
PDUFA IV Is “Golden Opportunity” To Improve Drug Safety Funding And Staff
The current round of reauthorization of the Prescription Drug User Fee Act presents a "golden opportunity" to improve FDA's regulation of drug safety, according to the Institute of Medicine's Assessment of the U.S. Drug Safety System Committee
Drug Safety Bill Authorizes Fines On Industry, But Does Not Include User Fees
The Center for Postmarket Drug Evaluation & Research proposed in legislation from Sens. Grassley and Dodd would be funded by appropriations, not user fees